UBS AM
BVS icon

UBS AM’s Bioventus BVS Stock Holding History

UBS AM’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.95K Hold
736
– – ﹤0.01% 3348
2026
Q1 		$6.72K Buy
+736
New +$6.17K ﹤0.01% 3396
2025
Q3 		– Sell
-144,435
Closed -$956K – 2336
2025
Q2 		$956K Buy
144,435
+64,936
+82% +$460K ﹤0.01% 2395
2025
Q1 		$727K Buy
79,499
+14,344
+22% +$143K ﹤0.01% 2418
2024
Q4 		$684K Buy
+65,155
New +$771K ﹤0.01% 2489
2023
Q1 		– Sell
-55,511
Closed -$145K – 2682
2022
Q4 		$145K Buy
+55,511
New +$242K ﹤0.01% 2476
2021
Q4 		– Sell
-388,533
Closed -$5.5M – 2853
2021
Q3 		$5.5M Sell
388,533
-11,295
-3% -$174K ﹤0.01% 1314
2021
Q2 		$7.04M Buy
+399,828
New +$6.44M ﹤0.01% 1238

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM's BVS Position: Q2 2026 in Review

UBS AM held its Bioventus (BVS) position steady in Q2 2026 at 736 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #3348.

UBS AM first reported a position in BVS in Q2 2021 and has held it in 8 quarters since. The position peaked at $7.04M in Q2 2021. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • UBS AM held 736 shares of Bioventus worth $6.95K as of Q2 2026.
  • UBS AM left its Bioventus share count unchanged in Q2 2026.
  • Bioventus made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3348 holding.
  • UBS AM first reported a position in Bioventus in Q2 2021 and has held it in 8 quarters since.
  • UBS AM's Bioventus position peaked at $7.04M in Q2 2021.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.